Endoglin and alk1 as therapeutic targets for hereditary hemorrhagic telangiectasia

Taylor and Francis Group, Expert Opinion on Therapeutic Targets, 10(21), p. 933-947, 2017

Journal article published in 2017 by Lidia Ruiz-Llorente, Eunate Gallardo-Vara, Elisa Rossi

, David M. Smadja, Luisa M. Botella, Carmelo Bernabeu

This paper is available in a repository.

Full text: Download

Preprint: archiving forbidden

Postprint: archiving restricted

Upload

Published version: archiving forbidden

Policy details

Data provided by